Piershale Financial Group’s CVS Health CVS Stock Holding History

Piershale Financial Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$9.33K	Buy	135 +1	+0.7%	+$71	0.01%	122
2023 Q1	$9.95K	Buy	134 +1	+0.8%	+$84	0.01%	112
2022 Q4	$12.4K	Buy	+133	New	+$12.8K	0.01%	97
2016 Q4	–	Sell	-113	Closed	-$10K	–	43
2016 Q3	$10K	Buy	113 +1	+0.9%	+$94	0.01%	88
2016 Q2	$11K	Hold	112	–	–	0.01%	84
2016 Q1	$12K	Buy	112 +1	+0.9%	+$97	0.01%	74
2015 Q4	$11K	Hold	111	–	–	0.01%	110
2015 Q3	$11K	Hold	111	–	–	0.01%	74
2015 Q2	$12K	Sell	111 -129	-54%	-$13.2K	0.01%	71
2015 Q1	$25K	Buy	240 +130	+118%	+$13.2K	0.02%	50
2014 Q4	$11K	Hold	110	–	–	0.01%	99
2014 Q3	$9K	Buy	110 +1	+0.9%	+$79	0.01%	89
2014 Q2	$8K	Hold	109	–	–	0.01%	105
2014 Q1	$8K	Buy	109 +1	+0.9%	+$71	0.01%	85
2013 Q4	$8K	Hold	108	–	–	0.01%	72
2013 Q3	$6K	Hold	108	–	–	0.01%	83
2013 Q2	$6K	Buy	+108	New	+$6.26K	0.01%	68

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Piershale Financial Group's CVS Position: Q2 2023 in Review

Piershale Financial Group increased its CVS Health (CVS) stake by 0.75% in Q2 2023, buying an estimated $71 and bringing the position to 135 shares worth $9.33K. The position accounts for 0.01% of the portfolio, ranked #122.

Piershale Financial Group first reported a position in CVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $25K in Q1 2015. 2,204 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

Piershale Financial Group held 135 shares of CVS Health worth $9.33K as of Q2 2023.
Piershale Financial Group bought 1 CVS Health share in Q2 2023, an estimated $71.
CVS Health made up 0.01% of Piershale Financial Group's portfolio in Q2 2023, its #122 holding.
Piershale Financial Group first reported a position in CVS Health in Q2 2013 and has held it in 17 quarters since.
Piershale Financial Group's CVS Health position peaked at $25K in Q1 2015.
2,204 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Piershale Financial Group's 13F filing for Q2 2023, filed 6 Jul 2023.